Menu

NIH Expands Undiagnosed Diseases Program

The National Institutes of Health is funding six extramural medical centers to help identify the causes of mysterious diseases.

Jul 3, 2014
Tracy Vence

FLICKR, RVOEGTLIThe National Institutes of Health (NIH) is giving six additional medical centers a total of $43 million to take part in its Undiagnosed Diseases Network, through which the agency is supporting research to unravel the causes of prolonged, mysterious conditions. The network is an extramural expansion of the agency’s Undiagnosed Diseases Program, which is headquartered at the Clinical Center on the NIH campus in Bethesda, Maryland.

Investigators from the Baylor College of Medicine, Boston Children’s Hospital, Duke University, Stanford University, the University of California, Los Angeles, and the Vanderbilt University Medical Center will now take part in a program that’s using genomic and other approaches, to ascertain the causes of rare, idiopathic conditions.

“We believe that there is a substantial unmet demand for the diagnoses of conditions that have perplexed skillful physicians,” grant recipient Isaac Kohane, a professor of pediatrics at Harvard Medical School and Boston Children’s Hospital, said in an NIH statement. “We want to address inquiries from physicians and patients throughout the country who require these services and, in doing so, create a 21st century model for diagnosis and treatment in this genomic and information-intensive era.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.